var data={"name":"Lupus","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Antiphospholipid antibody syndrome","type":"SUBSECTION","items":[{"name":"Antiphospholipid syndrome and the kidney","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antiphospholipid-syndrome-and-the-kidney"},{"name":"Clinical manifestations of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-of-antiphospholipid-syndrome"},{"name":"Diagnosis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-antiphospholipid-syndrome"},{"name":"Management of antiphospholipid syndrome in pregnant and postpartum women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-antiphospholipid-syndrome-in-pregnant-and-postpartum-women"},{"name":"Pathogenesis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-antiphospholipid-syndrome"},{"name":"Treatment of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-antiphospholipid-syndrome"}]},{"name":"Autoantibodies and diagnosis","type":"SUBSECTION","items":[{"name":"Antibodies to double-stranded (ds)DNA, Sm, and U1 RNP","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antibodies-to-double-stranded-ds-dna-sm-and-u1-rnp"},{"name":"Antiribosomal P protein antibodies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antiribosomal-p-protein-antibodies"},{"name":"Clinical significance of antinuclear antibody staining patterns and associated autoantibodies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-significance-of-antinuclear-antibody-staining-patterns-and-associated-autoantibodies"},{"name":"Diagnosis and differential diagnosis of systemic lupus erythematosus in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-differential-diagnosis-of-systemic-lupus-erythematosus-in-adults"},{"name":"Diagnosis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-of-antiphospholipid-syndrome"},{"name":"Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnostic-approach-to-the-neuropsychiatric-manifestations-of-systemic-lupus-erythematosus"},{"name":"Management of antiphospholipid syndrome in pregnant and postpartum women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-antiphospholipid-syndrome-in-pregnant-and-postpartum-women"},{"name":"Measurement and clinical significance of antinuclear antibodies","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=measurement-and-clinical-significance-of-antinuclear-antibodies"},{"name":"The anti-Ro/SSA and anti-La/SSB antigen-antibody systems","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-anti-ro-ssa-and-anti-la-ssb-antigen-antibody-systems"}]},{"name":"Cutaneous manifestations","type":"SUBSECTION","items":[{"name":"Livedoid vasculopathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=livedoid-vasculopathy"},{"name":"Overview of cutaneous lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-cutaneous-lupus-erythematosus"}]},{"name":"Drug-induced lupus","type":"SUBSECTION","items":[{"name":"Drug-induced lupus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drug-induced-lupus"}]},{"name":"Miscellaneous manifestations","type":"SUBSECTION","items":[{"name":"Coronary heart disease in systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=coronary-heart-disease-in-systemic-lupus-erythematosus"},{"name":"Gastrointestinal manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=gastrointestinal-manifestations-of-systemic-lupus-erythematosus"},{"name":"Hematologic manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hematologic-manifestations-of-systemic-lupus-erythematosus"},{"name":"Musculoskeletal manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=musculoskeletal-manifestations-of-systemic-lupus-erythematosus"},{"name":"Neonatal lupus: Epidemiology, pathogenesis, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neonatal-lupus-epidemiology-pathogenesis-clinical-manifestations-and-diagnosis"},{"name":"Neonatal lupus: Management and outcomes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neonatal-lupus-management-and-outcomes"},{"name":"Non-coronary cardiac manifestations of systemic lupus erythematosus in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=non-coronary-cardiac-manifestations-of-systemic-lupus-erythematosus-in-adults"},{"name":"Overview of and approach to the vasculitides in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-and-approach-to-the-vasculitides-in-adults"},{"name":"Overview of the clinical manifestations of systemic lupus erythematosus in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-clinical-manifestations-of-systemic-lupus-erythematosus-in-adults"},{"name":"Pulmonary manifestations of systemic lupus erythematosus in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pulmonary-manifestations-of-systemic-lupus-erythematosus-in-adults"}]},{"name":"Neuropsychiatric disease","type":"SUBSECTION","items":[{"name":"Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnostic-approach-to-the-neuropsychiatric-manifestations-of-systemic-lupus-erythematosus"},{"name":"Neurologic manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neurologic-manifestations-of-systemic-lupus-erythematosus"},{"name":"Neuropsychiatric manifestations of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neuropsychiatric-manifestations-of-systemic-lupus-erythematosus"}]},{"name":"Overlap syndromes","type":"SUBSECTION","items":[{"name":"Clinical manifestations of mixed connective tissue disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-of-mixed-connective-tissue-disease"},{"name":"Definition and diagnosis of mixed connective tissue disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=definition-and-diagnosis-of-mixed-connective-tissue-disease"},{"name":"Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=undifferentiated-systemic-rheumatic-connective-tissue-diseases-and-overlap-syndromes"}]},{"name":"Pathogenesis","type":"SUBSECTION","items":[{"name":"Epidemiology and pathogenesis of systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-pathogenesis-of-systemic-lupus-erythematosus"},{"name":"Pathogenesis of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-antiphospholipid-syndrome"}]},{"name":"Pregnancy","type":"SUBSECTION","items":[{"name":"Approach to contraception in women with systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-contraception-in-women-with-systemic-lupus-erythematosus"},{"name":"Management of antiphospholipid syndrome in pregnant and postpartum women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-antiphospholipid-syndrome-in-pregnant-and-postpartum-women"},{"name":"Menstrual function, menopause, and hormone replacement therapy in women with systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=menstrual-function-menopause-and-hormone-replacement-therapy-in-women-with-systemic-lupus-erythematosus"},{"name":"Neonatal lupus: Epidemiology, pathogenesis, clinical manifestations, and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neonatal-lupus-epidemiology-pathogenesis-clinical-manifestations-and-diagnosis"},{"name":"Neonatal lupus: Management and outcomes","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=neonatal-lupus-management-and-outcomes"},{"name":"Pregnancy in women with systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pregnancy-in-women-with-systemic-lupus-erythematosus"}]},{"name":"Renal disease","type":"SUBSECTION","items":[{"name":"Antiphospholipid syndrome and the kidney","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antiphospholipid-syndrome-and-the-kidney"},{"name":"Clinical features and therapy of lupus membranous nephropathy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-and-therapy-of-lupus-membranous-nephropathy"},{"name":"Diagnosis and classification of renal disease in systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=diagnosis-and-classification-of-renal-disease-in-systemic-lupus-erythematosus"},{"name":"End-stage renal disease due to lupus nephritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=end-stage-renal-disease-due-to-lupus-nephritis"},{"name":"General principles of the use of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-the-use-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"Therapy of resistant or relapsing diffuse or focal proliferative lupus nephritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=therapy-of-resistant-or-relapsing-diffuse-or-focal-proliferative-lupus-nephritis"},{"name":"Treatment and prognosis of diffuse or focal proliferative lupus nephritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-diffuse-or-focal-proliferative-lupus-nephritis"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Coronary heart disease in systemic lupus erythematosus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=coronary-heart-disease-in-systemic-lupus-erythematosus"},{"name":"Determinants of glucocorticoid dosing","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=determinants-of-glucocorticoid-dosing"},{"name":"General principles of the use of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-principles-of-the-use-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"General toxicity of cyclophosphamide in rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=general-toxicity-of-cyclophosphamide-in-rheumatic-diseases"},{"name":"Major side effects of systemic glucocorticoids","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=major-side-effects-of-systemic-glucocorticoids"},{"name":"Mycophenolate: Overview of use and adverse effects in the treatment of rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=mycophenolate-overview-of-use-and-adverse-effects-in-the-treatment-of-rheumatic-diseases"},{"name":"Overview of the management and prognosis of systemic lupus erythematosus in adults","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-management-and-prognosis-of-systemic-lupus-erythematosus-in-adults"},{"name":"Preoperative evaluation and perioperative management of patients with rheumatic diseases","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=preoperative-evaluation-and-perioperative-management-of-patients-with-rheumatic-diseases"},{"name":"Treatment and prognosis of diffuse or focal proliferative lupus nephritis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-and-prognosis-of-diffuse-or-focal-proliferative-lupus-nephritis"},{"name":"Treatment of antiphospholipid syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-antiphospholipid-syndrome"}]}]}